glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
Glucocorticoids (GC) are extensively used to treat patients with systemic rheumatic diseases, which can improve their quality of life and substantially increase its span. At the same time their use is associated with the development of serious adverse reactions that cannot be always avoided. One of...
Saved in:
| Main Authors: | Natalia Vladimirovna Toroptsova, I A Baranova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2013-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/524 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLUCOCORTICOID-INDUCED OSTEOPOROSIS: DIAGNOSIS, PREVENTION, AND TREATMENT
by: N. V. Toroptsova
Published: (2014-09-01) -
OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01) -
The risk of fractures and the need for anti-osteoporotic treatment in patients with systemic sclerosis
by: A. О. Efremova, et al.
Published: (2021-02-01) -
Secondary prevention of osteoporosis and osteoporotic fractures in real clinical practice and possibilities of its improvement with strontium ranelate
by: Nataliya Vladimirovna Toroptsova
Published: (2012-03-01) -
Associations of absolute risk of osteoporotic fractures (FRAX®) and total cardiovascular risk (SCORE) in urban population of the Russian Federation
by: M. A. Myagkova, et al.
Published: (2019-11-01)